Table 2.
T1Gd | T2/FLAIR | |||||
---|---|---|---|---|---|---|
Necrosis | Enhancement with necrosis | Edema | ||||
Lacunarity | FD | Lacunarity | FD | Lacunarity | FD | |
All patients | ||||||
OS | 0.27915 | n.s. | 0.3074 | n.s. | 0.4817 | 1.6543 |
PFS | 0.6136 | 1.31265 | 0.3900 | n.s. | n.s. | n.s. |
Current SOC | ||||||
OS | 0.28125 | 1.31265 | 0.3980 | n.s. | 0.456 | 1.6621 |
PFS | 0.6136 | 1.31265 | 0.3923 | n.s. | n.s. | 1.5202 |
We show both overall survival (OS) and progression free survival (PFS) with those that were significant (unadjusted p < 0.05) in italics. The results that remained significant while adjusting for multiple comparisons are shown in bold (adjusted p < 0.05). The numerical value in the cell represents the optimal threshold of analyses that reached a level of significance. Results that did not show significance are indicated by "n.s" to represent "not significant".